EP3155017
IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.5.2015EP published:
10.1.2024EP application number:
15798956.7
EPO information:
European Patent Register
Max expiry date:
27.5.2035
Title in English:
IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCELanguage of the patent:
English
Timeline
Today
28.5.2015EP application
10.1.2024EP Publication
Owner
Name:
Mederis Diabetes, LLCAddress:
7515 Guinevere Drive, Sugar Land, Texas 77479, US
Inventor
Name:
NESTOR, John, J.Address:
Encinitas, CA 92024, US
Priority
Number:
201462004156 PDate:
28.5.2014Country:
US
Classification
Categories:
C07K 19/00, C07K 14/605, A61K 38/26, A61K 47/50, A61P 31/10